Archimedes Biodegradable Pancreaticobiliary Stent (BPS) - Fast - Polymeric biliary/pancreatic stent Australia - English - Department of Health (Therapeutic Goods Administration)

archimedes biodegradable pancreaticobiliary stent (bps) - fast - polymeric biliary/pancreatic stent

endotherapeutics pty ltd - 63968 - polymeric biliary/pancreatic stent - polymeric stent with a fluted, cross-sectional profile and containing two channels which spiral in a double helix down the length of the stent. the archimedes bps is designed to fit the natural curvature of the common bile duct and pancreatic duct. the ends of the archimedes bps are tapered to allow insertion through the papilla. the minimal strength retention time for the archimedes bps fast degradation profile is 12 days. the process in which archimedes bps degrades is through hydrolysis. the archimedes bps is used to drain obstructed biliary or pancreatic ducts and is indicated for obstructed biliary and pancreatic ducts. the archimedes bps fast degradation profile is intended to degrade over a period of 12 days.

Archimedes Biodegradable Pancreaticobiliary Stent (BPS) - Medium - Polymeric biliary/pancreatic stent Australia - English - Department of Health (Therapeutic Goods Administration)

archimedes biodegradable pancreaticobiliary stent (bps) - medium - polymeric biliary/pancreatic stent

endotherapeutics pty ltd - 63968 - polymeric biliary/pancreatic stent - polymeric stent with a fluted, cross-sectional profile and containing two channels which spiral in a double helix down the length of the stent. the archimedes bps is designed to fit the natural curvature of the common bile duct and pancreatic duct. the ends of the archimedes bps are tapered to allow insertion through the papilla. the minimal strength retention time for the archimedes bps medium degradation profile is 20 days. the process in which archimedes bps degrades is through hydrolysis. the archimedes bps is used to drain obstructed biliary or pancreatic ducts and is indicated for obstructed biliary or pancreatic ducts. the archimedes bps medium degradation profile is intended to degrade over a period of approximately 20 days.

Archimedes Biodegradable Pancreaticobiliary Stent (BPS) - Slow - Polymeric biliary/pancreatic stent Australia - English - Department of Health (Therapeutic Goods Administration)

archimedes biodegradable pancreaticobiliary stent (bps) - slow - polymeric biliary/pancreatic stent

endotherapeutics pty ltd - 63968 - polymeric biliary/pancreatic stent - polymeric stent with a fluted, cross-sectional profile and containing two channels which spiral in a double helix down the length of the stent. the archimedes bps is designed to fit the natural curvature of the common bile duct and pancreatic duct. the ends of the archimedes bps are tapered to allow insertion through the papilla. the minimal strength retention time for the archimedes bps slow degradation profile is 11 weeks. the process in which archimedes bps degrades is through hydrolysis. the archimedes bps is used to drain obstructed biliary or pancreatic ducts and is indicated for obstructed biliary and pancreatic ducts. the archimedes bps slow degradation profile is intended to degrade over a period of 11 weeks.

LAZANDA- fentanyl citrate spray United States - English - NLM (National Library of Medicine)

lazanda- fentanyl citrate spray

archimedes pharma us inc. - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - fentanyl 100 ug - lazanda (fentanyl) nasal spray is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. patients considered opioid tolerant are those who are taking at least: 60 mg of oral morphine/day, 25 mcg of transdermal fentanyl/hour, 30 mg oral oxycodone/day, 8 mg oral hydromorphone/day, 25 mg oral oxymorphone/day, or an equianalgesic dose of another opioid for a week or longer. patients must remain on around-the-clock opioids when taking lazanda. lazanda is contraindicated for patients who are not already tolerant to opioids because life-threatening respiratory depression and death could occur in patients not taking chronic opioids. for this reason, lazanda is contraindicated in the management of acute or postoperative pain, including headache/migraine, or dental pain. [4] lazanda is intended to be prescribed only by healthcare professionals who are knowledgeable of and

Broncus Medical Archimedes™ System Singapore - English - HSA (Health Sciences Authority)

broncus medical archimedes™ system

somnotec (s) pte. ltd. - general hospital - to display images of the anatomy to aid the physician in guiding endoscopic tools or catheters during navigation through the same anatomy. the archimedes software is indicated for displaying images of the tracheobronchial tree to aid the physician in guiding endoscopic tools or catheters in the pulmonary tract to a location in the tracheobronchial tree or lung tissue, and to enable marker placement within soft lung tissue. the archimedes software does not make a medical diagnosis and is not intended for pediatric use. when under fluoroscopy guidance, the software enables users to segment previously acquired 3d ct or other datasets and overlay and register these 3d segmented data sets with live fluoroscopy x-ray images of the same anatomy in order to support catheter/device navigation. the 3d segmented data set can be displayed with a color map annotation received from an external source. the archimedes access kit are used with a bronchoscope, navigated by the archimedes software.

amg ARCHIMEDES BPS Biodegradable Pancreaticobiliary Stent Singapore - English - HSA (Health Sciences Authority)

amg archimedes bps biodegradable pancreaticobiliary stent

alcare pharmaceuticals pte ltd - gastroenterology & urology - archimedes bps biodegradable pancreaticobiliary stent is used to drain obstructed biliary or pancreatic ducts and is indicated for obstructed biliary or pancreatic ducts.

PABRINEX N/A Solution for Inj/Inf Ireland - English - HPRA (Health Products Regulatory Authority)

pabrinex n/a solution for inj/inf

archimedes pharma uk limited - thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, nicotinamide, ascorbic acid, glucose (as monohydrate) - solution for inj/inf - n/a - vitamin b-complex with vitamin c

CHLORPHENAMINE 10 Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

chlorphenamine 10 mg/ml solution for injection

archimedes pharma uk limited - chlorphenamine maleate - solution for injection - 10 mg/ml - substituted alkylamines

THIOPENTAL SODIUM 500 Milligram Pdr for Soln for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

thiopental sodium 500 milligram pdr for soln for injection

archimedes pharma uk limited - thiopental sodium - pdr for soln for injection - 500 milligram - barbiturates, plain